1 / 118

HEPATITIS VIRUSES:

HEPATITIS VIRUSES:. 5 medically important hepatitis viruses: 1. Hepatitis A: infectious hepatitis 2. Hepatitis B: Serum hepatitis 3. Non-A, Non-B: HCV 4. Hepatitis D (delta agent/ Type D) 5. Hepatitis E : Enteric Hepatitis 6. Post transfusion: HGV

lindasanders
Download Presentation

HEPATITIS VIRUSES:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. HEPATITIS VIRUSES:

  2. 5 medically important hepatitis viruses: • 1. Hepatitis A: infectious hepatitis • 2. Hepatitis B: Serum hepatitis • 3. Non-A, Non-B: HCV • 4. Hepatitis D (delta agent/ Type D) • 5. Hepatitis E : Enteric Hepatitis • 6. Post transfusion: HGV Other viral causes: EB virus, CMV, Yellow fever, Enterovirus, Herpes virus

  3. ViralHepatitis Enterically transmitted “Infectious” A E NANB Viralhepatitis Parenterally transmitted B D C “Serum” F, G, ? other

  4. Hepatitis A Virus • Epidemic jaundice described by Hippocrates • Differentiated from hepatitis B in 1940s • Serologic tests developed in 1970s • Most commonly reported type of hepatitis in the United States

  5. Hepatitis A Virus: • Picornavirus (RNA) • Humans are only natural host • Stable at low pH • Inactivated by high temperature, formalin, chlorine

  6. HEPATITIS A VIRUS • Causes Hepatitis A infection • It is a enterovirus, family picornaviridae • Recently classified under Hepatoviruses • ss RNA • Non-enveloped • Icosahedral nucleocapsid • Replicates in the cytoplasm of the cell (Intracytoplasmic)

  7. Also known as enterovirus 72 • It has 1 serotype • It has no antigenic relationship b/w hepatitis B or other hepatitis viruses Replication- similar to enteroviruses. Eg-polio virus.

  8. Source of Hepatitis A Infection

  9. Incubation period: Average 30 days Range 15-50 days • Jaundice by <6 yrs, <10%age group: 6-14 yrs, 40%-50% >14 yrs, 70%-80% • Complications: Fulminant hepatitis Cholestatic hepatitis Relapsing hepatitis • Chronic sequelae: None

  10. Transmission • Close personal contact(e.g., household contact, sex contact, child day care centers) • Contaminated food, water(e.g., infected food handlers, raw shellfish) • Blood exposure (rare)(e.g., injecting drug use, transfusion)

  11. Transmission and Epidemiology • Faeco-oral route • Reservoir :- humans • Children adolescents more commonly infected (an-icteric subclinical infection) • Adults: icteric manifestations • Virus is shed 2 weeks before & after appearance of symptoms.

  12. Institutional outbreaks recorded. Eg- day care centres, hostels, ICU • Outbreaks directly related to sanitation. Eg- fecal contamination of drinking water, food grown in polluted water, street food. • Rarely transmitted by blood. Eg- seen rarely with haemophiliacs transfused with blood products

  13. There is no chronic infection unlike in HBV or HCV because generally level of viremia is low. • Many people maybe infected and recovered (IgA seen in 50-70% of population) • Secondary attack rate in house hold contacts common

  14. Global Patterns of Hepatitis A Virus Transmission Disease Peak Age Endemicity Rate of Infection Transmission Patterns High Low to Early Person to person; High childhood outbreaks uncommon Moderate High Late Person to person; childhood/ food and waterborne young adults outbreaks Low Low Young adults Person to person; food and waterborne outbreaks Very low Very low Adults Travelers; outbreaks uncommon

  15. Pathogenesis and immunity • Virus replicates in GI tract and spread to liver hematogenously • Hepatocytes are infected but mechanism of cell damage is unclear. • Cytotoxic T-cells may damage the hepatocytes infected with virus. • If infection is cleared damage will be repaired and there is no chronic infection

  16. Hepatitis from other virus usually indistinguishable pathologically (all look the same histo-pathologically)

  17. Immune response • IgM is detected at the appearance of jaundice • Peaks 2-3 weeks, disappears in 3-4 months • So IgM Ab to HAV is important in diagnosis of HAV. • 1-3 weeks after the IgM appears IgG is seen. • IgG: provides life long immunity

  18. Hepatitis A Infection Typical Serological Course Total anti-HAV Symptoms Titre ALT Fecal HAV IgM anti-HAV 4 5 6 12 24 0 1 2 3 Months after exposure

  19. Clinical features • Incubation period (2-4 weeks) • Pre-Icteric phase: fever, nausea ,vomiting • Icteric Phase: jaundice, dark urine, pale stools, eleavtedtransaminases.

  20. Spontaneous recovery is the rule in 2-3 weeks time • Most of the cases maybe asymptomatic (maybe solely detected on basis of IgGAb) • No chronic hepatitis or chronic carrier state • So no predisposition to hepatocellular carcinoma

  21. Laboratory diagnosis • Biochemical investigations- LFT • Detection of anti HAV IgM, IgG: persists for decades • Detection of HAV particles: Immuno-electon microscopy (IEM) of faeces, liver, bile • HAV antigen detection: by ELISA • Isolation in cell culture possible but not routinely done • PCR: viral RNA

  22. Hepatitis A Vaccines: • Inactivated whole virus • HAVRIX (GlaxoSmithKline) • VAQTA (Merck Vaccine Division) • Pediatric and adult formulations • Licensed for persons >2 years

  23. Treatment and prevention • No antiviral therapy • Formaldehyde inactivated vaccine: vaccine: (virus grown in cell culture) given to children above 12 months & adults- initial dose and booster dose 6-12 months later

  24. Live attenuated vaccine: single dose , S/c • Detection of HAV antibody prior to vaccination is cost-effective • Passive immunization with immunoglobulin (HAV Ig) for post exposure prophylaxis can prevent disease in close household contacts & travellers

  25. Proper hygiene and superior sewage disposal, hand washing after bowel movements etc • Good sanitation help prevent (like for any food/water borne diseases) • Chlorination of water also helps.

  26. Hepatitis B Virus

  27. 5 medically important viruses are described as Hepatitis virus namely- • 1. Hepatitis A(HAV) • 2. Hepatitis B(HBV) • 3. Non-A, Non-B – HCV is most common • 4. Hepatitis D (delta agent or HDV) • 5. Hepatitis E(HEV) • 6. Post transfusion- HGV –causative role unknown Others can cause inflammation of the hepatocytes but not included- EB virus, CMV, Yellow fever, Enterovirus, Herpes virus

  28. ViralHepatitis Enterically transmitted “Infectious” A E NANB Viralhepatitis Parenterally transmitted B D C “Serum” F, G, ? other

  29. HEPATITIS B VIRUS • Causes Hepatitis B (HBV) PROPERTIES- • DNA virus, Hepadnaviridae Family • Icosahedral nucleocapsid containing partiallyds circular DNA genome.(all other Hepatitis group are RNA viruses).

  30. Envelope contains protein surface antigen(HBsAg) • HBsAg was first discovered in serum of Australian aborigine. So it is called Australia Antigen.

  31. MORPHOLOGY: • EM of serum from infected patients reveals 3 morphologic forms:

  32. HBV: Structure

  33. GENOME

  34. 4 genes –S, C , P, X • S- region S- codes for major S S+pre S2- codes for M - HBsAg S+ pre S1 and S2- codes for L • C- region C - - HBcAg C+pre C - - HBeAg • P - - DNA polymerase • X - enhance HBxAg - maybe to exist as co-infection in AIDS, In chronic hepatitis, in hepato-cellular carcinoma

  35. HBV Structure & Antigens Dane particle HBsAg = surface (coat) protein ( 4 phenotypes : adw, adr, ayw and ayr) HBcAg = inner core protein (a single serotype) HBeAg = secreted protein; function unknown

  36. Epidemiologically: 4 serotypes of HBV (HBsAg) • ‘a’ – group specific antigen • ‘d’ or ‘y’ 2 sets of neutrally exclusive epitopes • ‘w’ or ‘r’ • adw, adr, ayw and ayr are the serotypes • ayw-West Asia, Mid-east to West & North India • adw- Europe, Australia, Americas • adr- South and East India, Far East. • ayr- very rare.

  37. Transmission and epidemiology- 3 main modes- • Blood, blood products, IV drug abuse • Sexual contact • Perinatally from mother to new born • Very small amount of blood necessary for transmission. Eg. Needle stick injury

  38. Concentration of Hepatitis B Virus in Various Body Fluids Low/Not High Moderate Detectable blood semen urine serum vaginal fluid feces wound exudates saliva sweat tears breastmilk

  39. Distribution • Worldwide, particularly prevalent in the oriental countries- including India. • These areas have high incidence of hepato-cellular carcinoma- hepatoma. • HBV is a tumor associated virus • Immunization against HBV in Taiwan has decreased the incidence of hepatoma. • HBV vaccine: first vaccine against human cancer

  40. Mutants- Few cases of Hepatitis B will be with mutant virus • Called as pre core mutants – so unable to synthesize HBcAg • Escape mutants – found in those with combined immunization- also called as ‘a’ antigen mutation. They may pose problem in prophylactic immunization.

  41. PATHOGENESIS OF HEPATITIS B: • Why is Hep B virus specific for liver cells? • Because virus specific receptor on cell membrane facilitates entry. • Transcription factors facilitating viral mRNA synthesis.

  42. Summary of the Replicative cycle • Viral entry- uncoating • Viral DNA polymerase synthesize missing portion of DNA • Closed dsDNA formed in nucleus of host cell • This DNA will act as template for mRNA synthesis with help of cellular mRNA polymerase • The mRNA formed functions for protein synthesis and also template for positive strand of DNA

More Related